myocardial infarction
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 7423 | VEGFB | vascular endothelial growth factor B | |
| 7804 | LRP8 | LDL receptor related protein 8 | |
| 9388 | LIPG | lipase G, endothelial type | |
| 10062 | NR1H3 | nuclear receptor subfamily 1 group H member 3 | |
| 10068 | IL18BP | interleukin 18 binding protein | |
| 51085 | MLXIPL | MLX interacting protein like | |
| 51206 | GP6 | glycoprotein VI platelet | |
| 79068 | FTO | FTO alpha-ketoglutarate dependent dioxygenase | |
| 120227 | CYP2R1 | cytochrome P450 family 2 subfamily R member 1 | |
| 339479 | BRINP3 | BMP/retinoic acid inducible neural specific 3 |
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 24179 | Agt | angiotensinogen | |
| 24185 | Akt1 | AKT serine/threonine kinase 1 | |
| 24310 | Ace | angiotensin I converting enzyme | |
| 24326 | Ednra | endothelin receptor type A | |
| 24511 | Itgb1 | integrin subunit beta 1 | |
| 24530 | Lcat | lecithin cholesterol acyltransferase | |
| 24600 | Nos3 | nitric oxide synthase 3 | |
| 24613 | Oprd1 | opioid receptor, delta 1 | |
| 24617 | Serpine1 | serpin family E member 1 | |
| 24770 | Ccl2 | C-C motif chemokine ligand 2 |
| UniProt ID | Protein Name | Source |
|---|---|---|
| P33533 | Delta-type opioid receptor | |
| P34975 | Kappa-type opioid receptor | |
| P47196 | RAC-alpha serine/threonine-protein kinase | |
| P47820 | Angiotensin-converting enzyme | |
| P48750 | Granulocyte-macrophage colony-stimulating factor | |
| P49134 | Integrin beta-1 | |
| P50282 | Matrix metalloproteinase-9 | |
| P61016 | Phospholamban | |
| P81155 | Non-selective voltage-gated ion channel VDAC2 | |
| Q5EGZ1 | Angiotensin-converting enzyme 2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025